Barclays PLC Optimize Rx Corp Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Optimize Rx Corp stock. As of the latest transaction made, Barclays PLC holds 30,574 shares of OPRX stock, worth $218,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,574
Previous 26,934
13.51%
Holding current value
$218,604
Previous $208,000
28.85%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding OPRX
# of Institutions
93Shares Held
12.2MCall Options Held
12KPut Options Held
23.4K-
Whetstone Capital Advisors, LLC Shawnee Mission, KS1.35MShares$9.66 Million2.12% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$8.4 Million0.0% of portfolio
-
Royce & Associates LP1.07MShares$7.65 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA936KShares$6.69 Million0.0% of portfolio
-
Blair William & CO Chicago, IL601KShares$4.3 Million0.01% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $129M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...